CCR 20th anniversary commentary: In the beginning, there was PS-341

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Beverly A Teicher, Kenneth C Anderson

Abstract

Proteasome inhibitors have a 20-year history in cancer therapy. The first proteasome inhibitor, bortezomib, a breakthrough treatment for multiple myeloma, moved rapidly through development from the bench in 1994 to first FDA approval in 2003. Clinical Cancer Research has chronicled the development of proteasome inhibitors with publication of reports on bortezomib, carfilzomib, and the oral proteasome inhibitor ixazomib (MLN9708).

References

Nov 15, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert Z OrlowskiSteven L Soignet
Jun 27, 2003·The New England Journal of Medicine·Paul G RichardsonKenneth C Anderson
Nov 12, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Owen A O'ConnorRobert Z Orlowski
Jul 5, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Dharminder ChauhanKenneth C Anderson
Feb 4, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Antonio Garcia-GomezMercedes Garayoa

❮ Previous
Next ❯

Citations

Nov 22, 2015·Expert Review of Anticancer Therapy·Massimo OffidaniPietro Leoni
Jul 4, 2015·Expert Opinion on Investigational Drugs·Massimo GentileSilvia Gentili
Mar 26, 2016·BMC Cancer·Jonghoon ParkKwang-Ai Won
Sep 16, 2015·Immunotherapy·Yu-Tzu Tai, Kenneth C Anderson
Jul 23, 2016·Expert Review of Hematology·Rebecca CitrinDavid T Teachey
Jan 5, 2018·Science Translational Medicine·Marsha C Lampi, Cynthia A Reinhart-King
Sep 4, 2019·Annual Review of Pharmacology and Toxicology·Lloyd D Fricker
Oct 31, 2017·Calcified Tissue International·Fabrizio AccardiNicola Giuliani
Feb 2, 2019·SLAS Technology·Victor OngEun Ji Chung
Sep 8, 2017·Molecular Cancer Therapeutics·Ronan Le MoigneMark Rolfe
Mar 4, 2021·Journal of Medicinal Chemistry·Rao SongTao Yang
Jun 22, 2021·ACS Pharmacology & Translational Science·Rachel L Mynott, Craig T Wallington-Beddoe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Related Papers

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Clint T AllenCarter Van Waes
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Navjotsingh Pabla, Alex Sparreboom
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Douglas Yee
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
John MendelsohnNeil I Goldstein
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Torsten O Nielsen, Charles M Perou
© 2022 Meta ULC. All rights reserved